CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the company will be presenting at the 17th Annual Future Leaders in the Biotech Industry Conference at 3:00 p.m. EDT on April 8, 2010, in New York City.
